FDA Asks Congress for New Authority To Regulate CBD
When addressing the Food and Drug Administration’s (FDA) reluctancy to develop new regulations for cannabidiol…
When addressing the Food and Drug Administration’s (FDA) reluctancy to develop new regulations for cannabidiol…
Some patients that have recovered from a COVID-19 infection experience what the CDC has termed…
On May 11, 2022, Aimed Alliance’s staff attorney, Ashira Vantrees, participated as a panelist on…
In its 2023 Notice of Benefit and Payment Parameters Proposed Rule (2023 NBPP), the U.S.…
On April 13, the Food and Drug Administration published a draft guidance on “Diversity Plans…
On April 14, 2022, Michigan joined a growing number of states that can now offer…
On April 5, 2022, the Biden Administration announced that the Treasury Department and the Internal…
On March 25, 2022, Aimed Alliance sent a letter to the Minnesota House of Representatives…
On March 29, 2022, Aimed Alliance hosted a webinar through HR.com titled “Covering Prescription Digital…
On February 9, 2022, Aimed Alliance hosted a webinar titled “Copay Accumulators 101: Everything You…